期刊文献+

Metabolism-associated genes in occurrence and development of gastrointestinal cancer:Latest progress and future prospect

下载PDF
导出
摘要 Gastrointestinal(GI)cancer remains one of the most prevalent cancers in the world.The occurrence and progression of GI cancer involve multiple events.Metabolic reprogramming is one of the hallmarks of cancer and is intricately related to tumorigenesis.Many metabolic genes are involved in the occurrence and development of GI cancer.Research approaches combining tumor genomics and metabolomics are more likely to provide deeper insights into this field.In this paper,we review the roles of metabolism-associated genes,especially those involved in the regulation pathways,in the occurrence and progression of GI cancer.We provide the latest progress and future prospect into the different molecular mechanisms of metabolism-associated genes involved in the occurrence and development of GI cancer.
出处 《World Journal of Gastrointestinal Oncology》 SCIE 2021年第8期758-771,共14页 世界胃肠肿瘤学杂志(英文版)(电子版)
  • 相关文献

参考文献3

二级参考文献54

  • 1Jin-Lian Chen,Jun-Duo Hu,Jing Fan,Jing Hong,Department of Gastroenterology,Shanghai Sixth People’s Hospital,Shanghai Jiao Tong University,Shanghai 200233,China Hui-Qing Tang,Jian-Zhong Gu,Shanghai Laboratory Animal Center,Chinese Academy of Sciences,Shanghai 201615,China.Metabolomics of gastric cancer metastasis detected by gas chromatography and mass spectrometry[J].World Journal of Gastroenterology,2010,16(46):5874-5880. 被引量:12
  • 2KatherineDCrew,AlfredINeugut.Epidemiology of gastric cancer[J].World Journal of Gastroenterology,2006,12(3):354-362. 被引量:188
  • 3Atsushi Tashiro,Masatoshi Sano,Koichi Kinameri,Kazutaka Fujita,Yutaka Takeuchi.Comparing mass screening techniques for gastric cancer in Japan[J].World Journal of Gastroenterology,2006,12(30):4873-4874. 被引量:24
  • 4Galle J, Sittig D, Hanisch I, Wobus M, Wandel E, Loeffler M,Aust G. Individual cell-based models of tumor-environmentinteractions: Multiple effects of CD97 on tumor invasion. Am JPathol 2006; 169: 1802-1811 [PMID: 17071601 DOI: 10.2353/ajpath.2006.060006].
  • 5Aust G, Steinert M, Schütz A, Boltze C, Wahlbuhl M, HamannJ, Wobus M. CD97, but not its closely related EGF-TM7 familymember EMR2, is expressed on gastric, pancreatic, and esophagealcarcinomas. Am J Clin Pathol 2002; 118: 699-707 [PMID:12428789 DOI: 10.1309/A6AB-VF3F-7M88-C0EJ].
  • 6Martens GJ. Molecular biology of G-protein-coupled receptors.Prog Brain Res 1992; 92: 201-214 [PMID: 1338880 DOI: 10.1016/S0079-6123(08)61176-0].
  • 7Eichler W, Aust G, Hamann D. Characterization of an earlyactivation-dependent antigen on lymphocytes defined by themonoclonal antibody BL-Ac(F2). Scand J Immunol 1994; 39:111-115 [PMID: 8290889 DOI: 10.1111/j.1365-3083.1994.tb03348.x].
  • 8Veninga H, Becker S, Hoek RM, Wobus M, Wandel E, van derKaa J, van der Valk M, de Vos AF, Haase H, Owens B, van der PollT, van Lier RA, Verbeek JS, Aust G, Hamann J. Analysis of CD97expression and manipulation: antibody treatment but not genetargeting curtails granulocyte migration. J Immunol 2008; 181:6574-6583 [PMID: 18941248 DOI: 10.4049/jimmunol.181.9.6574].
  • 9Han SL, Xu C, Wu XL, Li JL, Liu Z, Zeng QQ. The impact ofexpressions of CD97 and its ligand CD55 at the invasion front onprognosis of rectal adenocarcinoma. Int J Colorectal Dis 2010; 25:695-702 [PMID: 20339853 DOI: 10.1007/s00384-010-0926-5].
  • 10Steinert M, Wobus M, Boltze C, Schütz A, Wahlbuhl M, Hamann J,Aust G. Expression and regulation of CD97 in colorectal carcinomacell lines and tumor tissues. Am J Pathol 2002; 161: 1657-1667[PMID: 12414513 DOI: 10.1016/S0002-9440(10)64443-4].

共引文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部